Gelonghui August 21st 丨*ST Pharmaceutical (600671.SH) announced that the company plans to issue shares to Qingdao Huilong Huase Investment Co., Ltd. (“Huilong Huase”). The number of shares to be issued is 365.33,54 million shares, and the total capital raised is about 278 million yuan. After deducting related issuance expenses, it is intended to be used by Tianmu Pharmaceutical to supplement liquidity and repay debts.
*ST目药(600671.SH)：拟向汇隆华泽定增募资2.78亿元，用于补充流动资金和偿还债务
*ST Pharmaceutical (600671.SH): It is proposed to raise an additional capital of 278 million yuan from Huilong Huazeding to supplement liquidity and repay debts
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.